Ophthalmology

Atlanta-based EyeSouth Partners has affiliated with Pittsburgh-based North Park Ophthalmology.

Clinical trial research organization Parexel has partnered with vision healthcare organization MyEyeDr to collaborate on recruitment for diabetic retinopathy and macular degeneration clinical trials. 

ASC and ophthalmology management services organization Sunvera Group has partnered with Mentor, Ohio-based Ophthalmic Physicians Incorporated and its affiliates. 

Nashville, Tenn.-based eyecare pharmaceutical company Harrow has acquired the U.S. commercial rights to five FDA-approved ophthalmic medications from Novartis for $175 million. 

Clinical trial management company Vial has added retina specialist Veeral Sheth, MD, to its scientific advisory board. 

Private equity-backed ophthalmology services provider Vision Innovation Partners has completed four practice acquisitions in 2022, bringing its total number of practices to 24.

Vision Innovation Partners inked a partnership with Chesen Laser Eye Center in Reading, Pa.

Cumming Ophthalmic Research and Development has filed an application for premarket approval with the U.S. Food and Drug Administration for a lens to help treat cataracts. 

Atlanta-based ophthalmology management services organization EyeSouth Partners made several moves in 2022, including its acquisition by Olympus Partners and multiple affiliations.

The FDA has issued new draft guidance warning patients about the risks associated with LASIK surgery, according to a Dec. 7 report from the The New York Times.